Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia

Analysis of the efficacy and the compatibility of deep regional hyperthermia in combination with radiotherapy and chemoradiotherapy in bladder cancer

Trial Details

NCT ID
NCT05397262
Phase
NA
Sponsor
University of Erlangen-Nürnberg Medical School
Status
RECRUITING
Cancer Type
Bladder Cancer
Interventions
  • Hyperthermia
  • Radiotherapy
  • Chemotherapy 5-Fluorouracil
  • Chemotherapy Cisplatin
Locations (sample)
  • Erlangen, Germany|49.59099,11.00783

Key Eligibility Criteria

  • Age ≥ 18 years
  • Histologically confirmed bladder cancer
  • ECOG-performance status ≤ 2
  • Informed consent

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Bladder Cancer Trials on Trialify →